President Trump ordering pharma companies to lower drug prices in the United States over the next 60 days. Joining us right now to talk about this and changes at the FDA, plus much more, is former FDA commissioner Scott Gotautle. He's also a CNBC contributor and a board member of both Aluminina and Fizer.And Scott, let's talk through what this might mean. This is a a strict letter. President Trump tried to do this in the first Trump administration with an executive order that the courts struck down.How like ...

AstraZeneca CEO broke ranks with his pharmaceutical industry peers Tuesday, saying he was open to aligning drug prices globally https://t.co/eQHyxQ8wwF ...